Changes in mental state and behaviour in Huntington's disease

Area of Science:

• Neuroscience
• Psychiatry
• Genetics

Background:

• Huntington's disease (HD) has historically been associated with changes in mental state and behavior, including disinhibition and impaired social cognition.
• Behavioral and psychiatric symptoms in HD can precede motor deficits and are often the most debilitating aspects of the disease.
• Current pharmacological treatments for psychiatric symptoms in HD lack a robust evidence base, and effective treatments for apathy and cognitive decline are unavailable.

Purpose of the Study:

• To review the current understanding of social cognitive impairments in Huntington's disease.
• To highlight the need for therapeutic interventions targeting these impairments.
• To emphasize the importance of developing standardized rating scales for clinical trials in HD.

Main Methods:

• Literature review of studies on behavioral and mental state changes in Huntington's disease.
• Analysis of existing therapeutic approaches and their evidence base.
• Discussion of the neuropathological underpinnings of social cognitive deficits in HD.

Main Results:

• Behavioral problems, including disinhibition and impaired social cognition, are recognized features of Huntington's disease.
• The evidence supporting current pharmacological treatments for psychiatric symptoms in HD is limited.
• There are no effective treatments for apathy and cognitive decline in Huntington's disease.

Conclusions:

• A better understanding of social cognitive impairments is crucial for managing Huntington's disease, but effective therapeutic interventions are needed.
• Future research should focus on developing reliable rating scales to assess behavioral and mental state changes in clinical trials.
• A unified conceptual framework integrating motor, cognitive, emotional, and behavioral aspects is essential for improved understanding and management of Huntington's disease.